INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M209. A total of 46 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
IMS Capital Management | 246,966 | $1,778,000 | 2.19% |
WELCH & FORBES LLC | 902,286 | $6,496,000 | 0.21% |
Alambic Investment Management, L.P. | 25,100 | $181,000 | 0.11% |
EMERSON INVESTMENT MANAGEMENT, LLC | 74,175 | $534,000 | 0.10% |
Hayek Kallen Investment Management | 10,965 | $79,000 | 0.06% |
Yellowstone Partners, LLC | 10,045 | $72,000 | 0.03% |
Ausdal Financial Partners, Inc. | 7,750 | $56,000 | 0.03% |
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 29,647 | $213,000 | 0.03% |
GROUP ONE TRADING, L.P. | 61,856 | $445,000 | 0.01% |
Cambridge Investment Research Advisors, Inc. | 10,500 | $76,000 | 0.00% |